The pharmaceutical suppositories market was valued for $1.66 billion in 2023 and is estimated to reach $3.23 billion by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.
Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.
The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness.
For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies’ efforts to raise public awareness of suppository benefits, further support market growth.
However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.
The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories.
On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use.
Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.
Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.
The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness.
For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies’ efforts to raise public awareness of suppository benefits, further support market growth.
However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.
The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories.
On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use.
Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update* (with the purchase of an enterprise license)
- 5 additional Company Profiles, pre- or post-purchase, as a free update.
- Free Updated Version (once released) with the purchase of an enterprise user license.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- Import Export Analysis/Data
Key Market Segments
By Prescription Type
- OTC
- Prescribed Suppositories
By Therapeutic Application
- Analgesics and Anti-Inflammatory Drugs
- Antiemetics
- Laxatives
- Hormonal Therapies
- Antifungals and Antibacterials
- Others
By Fill Volume Categories
- Small Fill Volumes
- Medium Fill Volumes
- Large Fill Volumes
By Type
- Rectal Suppositories
- Vaginal Suppositories
By Age Group
- Pediatric Use
- Adult Use
By Base
- Fatty Bases
- Water Miscible Base
- Type
- Glycero Gelatin Base
- Soap Glycerin Suppositories
- Polyethylene Glycol Bases
- Emulsifying Bases
- Type
- Witepsol
- Massa Esterium
- Massuppol
By Distribution Channel
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East And Africa
Key Market Players
- Bausch Health Companies Inc.
- Bayer AG
- Bliss GVS Pharma Ltd
- Church & Dwight Co. Inc.
- Cosette Pharmaceuticals, Inc.
- Intas Pharmaceuticals Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Zydus Lifesciences Limited
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE
CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION
CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES
CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP
CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
CHAPTER 13: COMPETITIVE LANDSCAPE
CHAPTER 14: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to the report, the pharmaceutical suppositories market was valued at $1.6 billion in 2022, and is estimated to reach $2.8 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032.The pharmaceutical suppositories market is likely to experience a significant growth rate of 5.7% from 2023-2032 owing to increasing market demand of rectal suppositories segment
Pharmaceutical suppositories are solid, medicated dosage forms designed for rectal or vaginal administration. These small, often bullet-shaped units contain active pharmaceutical ingredients (APIs) dispersed in a suitable base material. When inserted into the body, they gradually melt or dissolve, allowing for the controlled release and absorption of the medication. Suppositories are used in medical practice to deliver localized treatment, bypass the first-pass metabolism in the liver, and offer an alternative when oral or intravenous routes are not ideal. They are employed in a wide range of medical conditions, including pain management, gastrointestinal issues, hormone therapy, and more, providing targeted drug delivery with minimized systemic effects.The pharmaceutical suppositories market is experiencing significant growth driven by the growing prevalence of the geriatric population and the increasing incidence of acute and chronic diseases. As the world's population continues to age, there is a substantial rise in the number of elderly individuals who often require specialized medical treatments. Suppositories offer an effective and targeted drug delivery method, which is especially beneficial for older adults who may have difficulty swallowing or need localized treatment.
Moreover, the surge in acute and chronic diseases worldwide has bolstered the demand for suppositories. These dosage forms are crucial in managing various conditions such as constipation, pain, hemorrhoids, and inflammatory bowel diseases. For instance, according to the article published in Springer, in 2023, it states that average prevalence of constipation was estimated at 16% globally, while a prevalence of 33.5% was attributed to adults between 60 and 110 years old. This underscores the importance of suppositories in addressing healthcare needs, contributing to the growth of the pharmaceutical suppositories market as they provide effective solutions for patients of all ages.
Furthermore, the growing initiative taken by key players and the government organizations for awareness regarding use of suppositories are further driving the market growth. These initiatives are pivotal in market expansion by educating both healthcare professionals and the general public about the benefits and applications of suppository-based medications. By providing information and promoting the safe and effective use of suppositories, these stakeholders contribute to increased acceptance and utilization of this drug delivery method. Patients become more aware of the advantages of suppositories, while healthcare providers gain confidence in prescribing and administering them. This combined effort fosters a conducive environment for the pharmaceutical suppositories market to thrive, ultimately benefiting individuals who can benefit from these specialized and targeted treatment options.
The global pharmaceutical suppositories market is segmented based on type, base, distribution channel, end user, prescription type and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. On the basis of base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, it is classified into hospitals & clinics, home care and nursing home. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides a comprehensive analysis of the key players that operate in the global pharmaceutical suppositories market such as Bayer AG, Bliss Gvs Pharma Ltd, Viatris Inc, Cadila Healthcare Ltd, Church & Dwight Co., Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A. Key players operating in the market have adopted product approval as their key strategies to expand their product portfolio.
Key Market Insights (Updated)
- On the basis of type, the rectal suppositories segment dominated the market in terms of revenue in 2022. However, the vaginal suppositories segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of base, the emulsifying bases segment held largest market share in 2022 and is expected to remain dominant throughout the forecast period.
- On the basis of distribution channel, the hospital pharmacies segment dominated the market in terms of revenue in 2022. However, the online sales segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of end user, the hospitals & clinics segment dominated the market in terms of revenue in 2022. However, the home care segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of prescription type, the prescribed suppositories segment held the largest market share in 2022. However, the OTC segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of region, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Bausch Health Companies Inc.
- Bayer AG
- Bliss GVS Pharma Ltd
- Church & Dwight Co. Inc.
- Cosette Pharmaceuticals, Inc.
- Intas Pharmaceuticals Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Zydus Lifesciences Limited
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
